Literature DB >> 1721296

FK 506 and rapamycin: molecular probes of T-lymphocyte activation.

B E Bierer1, Y J Jin, D A Fruman, V Calvo, S J Burakoff.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1721296

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

Review 1.  Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review.

Authors:  J A Sivak-Callcott; J Rootman; S L Rasmussen; R A Nugent; V A White; D Paridaens; Z Currie; G Rose; B Clark; A A McNab; F V Buffam; J M Neigel; M Kazim
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

Review 2.  Autoimmune hepatitis. Evolving concepts and treatment strategies.

Authors:  A J Czaja
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

3.  Tacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shock.

Authors:  F Squadrito; D Altavilla; G Squadrito; M Ferlito; G M Campo; M Arlotta; S Grimaldi; C Quartarone; A Saitta; A P Caputi
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

Review 4.  Neural roles of immunophilins and their ligands.

Authors:  D M Sabatini; M M Lai; S H Snyder
Journal:  Mol Neurobiol       Date:  1997-10       Impact factor: 5.590

5.  Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A.

Authors:  D A Fruman; C B Klee; B E Bierer; S J Burakoff
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

6.  Induction of the FK506-binding protein, FKBP13, under conditions which misfold proteins in the endoplasmic reticulum.

Authors:  K T Bush; B A Hendrickson; S K Nigam
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.